Joshi, D.; Khursheed, R.; Gupta, S.; Wadhwa, D.; Singh, T.G.; Sharma, S.; Porwal, S.; Gauniyal, S.; Vishwas, S.; Goyal, S.;
et al. Biosimilars in Oncology: Latest Trends and Regulatory Status. Pharmaceutics 2022, 14, 2721.
https://doi.org/10.3390/pharmaceutics14122721
AMA Style
Joshi D, Khursheed R, Gupta S, Wadhwa D, Singh TG, Sharma S, Porwal S, Gauniyal S, Vishwas S, Goyal S,
et al. Biosimilars in Oncology: Latest Trends and Regulatory Status. Pharmaceutics. 2022; 14(12):2721.
https://doi.org/10.3390/pharmaceutics14122721
Chicago/Turabian Style
Joshi, Deeksha, Rubiya Khursheed, Saurabh Gupta, Diksha Wadhwa, Thakur Gurjeet Singh, Sumit Sharma, Sejal Porwal, Swati Gauniyal, Sukriti Vishwas, Sanjay Goyal,
and et al. 2022. "Biosimilars in Oncology: Latest Trends and Regulatory Status" Pharmaceutics 14, no. 12: 2721.
https://doi.org/10.3390/pharmaceutics14122721
APA Style
Joshi, D., Khursheed, R., Gupta, S., Wadhwa, D., Singh, T. G., Sharma, S., Porwal, S., Gauniyal, S., Vishwas, S., Goyal, S., Gupta, G., Eri, R. D., Williams, K. A., Dua, K., & Singh, S. K.
(2022). Biosimilars in Oncology: Latest Trends and Regulatory Status. Pharmaceutics, 14(12), 2721.
https://doi.org/10.3390/pharmaceutics14122721